Leader Extra Strength Acetaminophen Tablets — Class II drug recall D-0857-2020
Terminated recall by Contract Pharmacal Corporation, reported 2020-02-19, distributed nationwide. Presence of Foreign Tablets/Capsules: Complaint involving one Women's Prenatal dietary supplement tablet commi
| Recall number | D-0857-2020 |
|---|---|
| Product type | Drug |
| Classification | Class II |
| Status | Terminated |
| Voluntary or mandated | Voluntary |
| Recalling firm | Contract Pharmacal Corporation, Hauppauge, NY, United States |
| Recall initiated | 2020-02-03 |
| Classified | 2020-02-27 |
| Reported by FDA | 2020-02-19 |
| Terminated | 2024-04-22 |
| Distributed | Nationwide (US) |
| Quantity | 5,472 bottles |
| Reason classes | potency |
| UPC / GTIN / UDI-DI | 00096295138078 |
| Lot numbers | 08/21, 193005 |
Product
Leader Extra Strength Acetaminophen Tablets, 500 mg Pain Reliever/Fever Reducer,100-count bottles,Distributed by Cardinal Health, Dublin OHIO 43017 NDC 7000-0036-1, UPC 0 96295 13807 8
Reason for recall
Presence of Foreign Tablets/Capsules: Complaint involving one Women's Prenatal dietary supplement tablet commingled in a bottle of Extra Strength Acetaminophen 500 mg contents 1000 count bottle.
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-0857-2020. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.